aod9604 reconstitution AOD 9604 : r/Peptides AOD-9604 | AOD9604 Peptide |

It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways

Some users also highlight the compounds ability to target stubborn fat, with noticeable improvements in body composition over time

If you're isolating adipocyte behavior or testing lipolytic cascades independent of systemic metabolism, AOD-9604 offers specificity without spillover effects